Logo
x

Search category

Subscribe Now

Age-Relatedapproval

Novartis' Beovu (brolucizumab) Receives EC's Approval for Wet Age-Related Macular Degeneration

Novartis' Beovu (brolucizumab) Receives EC's Approval for Wet Age-Related Macular Degeneration

  • February 17, 2020
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.